Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Pharma Seeking Hospital Partnership in Heilongjiang Province

publication date: Jan 28, 2015
Shanghai Fosun Pharma is hoping to add another facility to its growing portfolio of for-profit hospitals. Fosun signed a framework agreement with the First Hospital of Qiqihar City, the second largest city in Heilongjiang Province, to partner on building a new hospital. Fosun will supply an undisclosed amount of cash for a 53% stake in the venture; First Hospital will contribute land and buildings for the remaining 47%. In addition, the two partners will form a joint venture to purchase drugs, devices, equipment and consumables for both First Hospital and the New Hospital, with a goal of lowering procurement costs. Fosun will own 51% of this second company. More details....

Stock Symbols: (SHA: 600196; HK: 02196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here